Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO 2018 Congress
  5. Exhibition
  6. Exhibitor Profiles

ESMO 2018: Exhibiting Companies

ESMO 2018 banner

10x Genomics

10xGenomics-logo

10x Genomics, Inc. is building tools for scientific discovery that reveal and address the true complexities of biology and disease. Through a combination of novel microfluidics, chemistry and bioinformatics, our award-winning Chromium System is enabling researchers around the world to more fully understand the fundamentals of biology at unprecedented resolution and scale.

AbbVie

SL-Abbvie

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to improve treatments across four therapeutic areas: immunology, oncology, virology and neuroscience.

Accell Clinical Research

accell-clinical-research-logo

Accell Oncology, Accell’s new brand, is the only oncology-specialized full-service clinical Contract Research Organization (CRO) in Eastern Europe and Russia with a relentless mission to complete every clinical trial on time. Founded in 2007 and backed by our strong operational strategy and leadership, a devoted team of medical professionals in 15+ countries and connections to prominent medical institutions, Accell guarantees each clinical trial to be our Client’s success.

Accord Healthcare

accord-logo

Accord Healthcare supports cancer patients with over 30 oncology therapies via our own commercial infrastructure. We recognise the importance of supportive care and we have a number of phase III products comprising a mix of biosimilars like Accofil® (G-CSF) and Pelgraz® (pegylated G-CSF), repurposed molecules as well as our own novel developments in our pipeline.

Advanced Accelerator Applications, a Novartis Company

advanced accelerator applications logo

Advanced Accelerator Applications, a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium 68 for diagnostic use, or lutetium 177 for therapy. AAA’s first theragnostic pairing includes diagnostic drugs NETSPOT® and SomaKit TOC® and therapeutic Lutathera®. 

Almac Diagnostics

almac logo

Almac Diagnostics is a stratified medicine company specialising in biomarker driven clinical trials. Our experience spans oncology, immunology, CNS and infective diseases.  Our global laboratories offer tailored solutions from discovery to commercialisation: Biomarker discovery. Custom assay development & validation. DNA and RNA panel solutions. Flexible CDx development & commercialisation. Expert regulatory support. Bioinformatics & software development. 

Amgen

amgen-logo-2013

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. 

Amoy Diagnostics Co., Ltd

Amoy Diagnostics

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits approved by CFDA and CE certified. In European EMQN and Chinese PQCC quality control programs, AmoyDx is NO.1 kit supplier for some years and always achieves the highest accuracy rate. 

Aptitude Health

aptitude-health

A leading provider of oncology insights for the life sciences industry. Our global portfolio of products and extensive physician network deliver the business intelligence and medical communications our clients need to innovate, drive the oncology market forward, and improve patient outcomes. We provide unparalleled access to global key-opinion leaders and market-driving US community physicians and their clinical practice.

Aptus Health

aptus-health

Aptus Health dynamically connects health and life sciences companies with healthcare professionals, healthcare consumers, and other members of the healthcare ecosystem. Univadis Oncology, provided by Aptus Health, is a digital platform with a set of dedicated resources for oncologists and trainees, with the aim to continually helping them stay current with the latest national and international clinical research and breakthroughs.

ArcherDX

archer logo

ArcherDX is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays.

AROG Pharmaceuticals

arog pharmaceuticals logo

Arog Pharmaceuticals, LLC is developing CRENOLANIB, an orally bioavailable, mutant specific type I inhibitor of receptor kinases FLT3, PDGFRa, and PDGFRb. Crenolanib is currently in phase III development in AML and GIST.

Astellas Pharma Europe Ltd.

SL-Astellas

Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide. We are committed to the fight against cancer and to making medicines available that can extend and improve the lives of those suffering from cancer, advancing treatments where there are real needs for patients.

AstraZeneca

Astra Zeneca Logo

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily in three main therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

BAXTER

baxter logo

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years we 've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. Our products, technologies and therapies are available in more than 100 countries.

Bayer

bayer logo 2018

Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise at Bayer includes now four marketed products and several other compounds in various stages of clinical development. Together, these products reflect the company’s approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated.

BBMRI-ERIC

BBMRI-ERIC

BBMRI-ERIC is the European research infrastructure for biobanking and biomolecular resources. We bring together 500+ biobanks across Europe, to create the largest biorepository in the world. We strive to make samples more accessible to all researchers and therefore #MakeNewTreatmentsPossible.

BEACON Medicare Limited

SL-Beacon-Medicare

BEACON Medicare Limited is a concern of BEACON Group and Global Marketing Partner of BEACON Oncology Limited. BEACON is the No-1 Oncology company and one of the leading pharma companies of Bangladesh. BEACON manufactures more than 100 life saving anti-cancer products which includes conventional chemotherapy, Monoclonal antibodies, Targeted therapies, Nano and Lyposomal preparations. After meeting the local demand, BEACON exports its medicines globally.

BeiGene, Ltd.

SL-Beigene

BeiGene is a global, commercial-stage, research-based biotechnology company focused on molecularly-targeted and immuno-oncology cancer therapeutics. With a team of over 1,300 employees in China, the United States, Australia and Switzerland, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is also working to create combination solutions aimed to have both a meaningful and lasting impact on cancer patients. BeiGene markets ABRAXANE® (nanoparticle albumin-bound paclitaxel), REVLIMID® (lenalidomide), and VIDAZA® (azacitidine) in China under a license from Celgene Corporation.

Biocartis

Biocartis 2018

Biocartis is an innovative molecular diagnostics (MDx) company providing MDx solutions with a focus in oncology. Its Idylla™ platform is a fully automated sample-to-result, real-time PCR (Polymerase Chain Reaction) system.

BioClinica

bioclinica logo

Bioclinica is a global life science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Our cloud-based offerings include medical imaging, cardiac safety, clinical adjudication, randomization and trial supply management, clinical trials management, electronic data capture and eSource, site payments, pharmacovigilance, and a network of investigative sites.

Biocytogen Boston Corporation

biocytogen logo

We are a professional service provider specializing in gene targeted animal model generation to support basic research, pre-clinical in vivo efficacy studies, pharmacological services for antibody drug discovery, and development.

We have developed four excellent platforms:

  1. Custom gene targeting service platform
  2. Immuno-oncology platform using human immune system reconstituted B-NDG mouse model
  3. Drug efficacy studies platform
  4. Antibody discovery service platform

BIOMAPAS

biomapas-logo

Biomapas – a Full Service CRO. We are a team of professionals experienced in Clinical Trials, Regulatory Affairs, Medical Writing and Pharmacovigilance services. For more than 17 years Biomapas is supporting Pharmaceutical, Biotech and Medtech companies with client based solutions in Europe, Russia, CIS and the Americas. We are an ISO 9001 and 13485 certified company since 2012.

Biopticon Corporation

biopticon-logo

Biopticon develops state-of-the-art scanning devices and data management software adaptable to a range of preclinical research studies. TumorImager-2, our second-generation handheld imager designed for subcutaneous tumors, generates accurate surface measurements and real-color 3D images. TumorManager seamlessly integrates study protocols and produces comprehensive metrics, statistical analyses, and publishable reports.

Bio-Rad Laboratories GmbH

bio rad laboratories logo

Bio-Rad Laboratories is a world leader in providing products for the life science research and diagnostic markets. In our Life Science Group, we build the industry leading solutions for oncology research, including the highly sensitive Droplet Digital™ PCR technology and our new technology for single-cell sequencing, the ddSEQ™ Single-Cell Isolator. 

Biotype Diagnostic GmbH

biotype diagnostics logo

Biotype develops, produces, and offers molecular diagnostic products and OEM-services. Aside from assays, the company provides the unique Modaplex technology, which enables the examination of up to fifty different DNA/RNA targets simultaneously and thus simplifies complexities in molecular diagnostic approaches. Biotype’s OEM-services cover all the challenges ranging from the idea up to marketable products on various platforms.

BMS Pfizer Alliance

BMS pfizer alliance logo

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in this field.

Boehringer Ingelheim International GmbH

SL-Boehringer-Ingelheim-blue

At Boehringer Ingelheim we are taking cancer on. We are collaborating with the oncology community to deliver scientific breakthroughs to transform the lives of patients. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer.

Bristol-Myers Squibb

Bristol Myers Squibb Logo 2015

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. We are focused on helping patients in disease areas including oncology, cardiovascular, immunoscience and fibrosis. Each day, our employees work together for patients – it drives everything we do.

Calithera Biosciences

calithera logo

Calithera is focused on discovering and developing small molecule drugs that slow tumor growth through controlling metabolic pathways in tumor and immune cells. Our investigational onco-metabolism medicines take advantage of the specific metabolic requirements of tumor cells and immune cells. Calithera is developing a glutaminase inhibitor and an arginase inhibitor in the clinic and has a pipeline of novel tumor metabolism candidates.

Caris Life Sciences 

SL-Caris

Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine. Caris Molecular Intelligence®, our molecular profiling service provides the most potentially clinically actionable treatment options available to personalize patient care. Caris’ ADAPT Biotargeting System™ is utilized for drug target identification, therapeutic discovery, fixed tissue-based companion diagnostics, blood-based cancer screening & biomarker identification.

Catalysis S.L.

catalysis logo

At Catalysis, we have developed alternatives to improve health with new nutritional remedies to relieve the suffering caused by widespread diseases like diabetes, immunodepression, hepatitis, cancer,etc. Oncoxin is intended to minimise the toxicity and side effects from aggressive therapies such as chemotherapy and radiotherapy and to be used as an adjuvant during the treatment.

Celgene

celgene-logo-2013

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

Celldex Therapeutics

  • Booth 228

Celltrion Healthcare Co. Ltd

celltrion healthcare logo

Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion through an extensive more than 120 different countries, including both developed and emerging markets.

CENTRE LEON BERARD

centre-leon-berard-logo

The Centre Léon Bérard is a Comprehensive cancer Centre based in Lyon, France. Our mission is to offer the best quality care to cancer patients. This management from the diagnosis to the most innovating treatments takes also into account nutrition, psychologic and rehabilitation aspects adapted to each patient. Over 500 researchers work on the same site beside specialists of the hospital.

Cepheid

cepheid logo

Cepheid is a leading on-demand molecular diagnostics company that is dedicated to improving healthcare by developing fully-integrated systems and accurate yet easy-to-use molecular tests. The company is focusing on applications where rapid and actionable test results are needed most, in fields such as critical and healthcare-associated infections, sexual health, genetic diseases,virology and cancer. 

Clinical Research Malaysia (CRM)

Clinical Research Malaysia CRM logo

Clinical Research Malaysia (CRM) is a government-owned company dedicated to promote and accelerate Industry Sponsored Research in the country. Our deep understanding of the local clinical research landscape and implementation of international standards coupled with fundamental backing of the Ministry of Health provide us an incomparable advantage to deliver research and create high skilled job opportunities.

Clovis Oncology

Clovis oncology

Clovis is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.

Cmed

cmed logo

Cmed is a technology-led CRO that specializes in oncology, immuno-oncology, cell therapy and other speciality therapeutics clinical trials. Our experienced industry professionals provide full CRO services, functional data management and analysis, and have developed encapsia®, a new generation data capture, management and analytics technology. encapsia® provides live, advanced insights and analytics allowing quick, data-driven decisions. 

Collaboration for Oncology Data in Europe (CODE)

code logo

The Collaboration for Oncology Data in Europe (CODE) aims to expand knowledge of anti-cancer medicines use in Europe by supporting the creation of a dedicated Oncology Data Network (ODN). The ODN has been designed to collate up-to-date information on anti-cancer medicine use in clinical practice for all forms of cancer, all patients and all treatment centres in Europe who wish to join.

Covance/Chiltern

covance chiltern logo

Covance® and Chiltern, a Covance company, make the drug development business of LabCorp. As the world’s most comprehensive drug development company, we are dedicated to advancing healthcare through a Designed Around You® experience and delivering Solutions Made Real®. Together with our clients, we transform today’s healthcare challenges into tomorrow’s solutions. 

Daiichi Sankyo Oncology Europe GmbH

Daiichi-Sankyo-Logo

Daiichi Sankyo and its 15.000 employees in more than 20 countries are dedicated to the creation and supply of innovative pharmaceutical products. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, the Group’s 2025 vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. Our European headquarters are in Munich, Germany and we have affiliates in 12 European countries.

DAVA Oncology

dava oncology logo

DAVA Oncology is the leading provider of clinical trial acceleration services and oncology drug development consulting products designed to accelerate research and development timelines. DAVA’s primary focus is to accelerate the successful completion of cancer clinical trials through the deployment of experienced medical oncologists.

Definiens

definiens logo

We improve patient lives by unlocking the tissue phenome. Our mission is to accelerate breakthroughs by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, bring multi-omics data into a cancer-relevant context, and facilitate the translation of new insights into novel therapies. 

Delcath Systems

delcath systems logo

Delcath Systems, is a specialty pharmaceutical and medical device company focused on oncology. Our proprietary product- the Delcath Hepatic Delivery System for use with Melphalan Hydrochloride -is designed to administer high dose chemotherapy to the liver, while controlling systemic exposure”.

Dignitana

delcath systems logo

Dignitana, a medical technology company based in Lund Sweden, produces the patented DigniCap® Scalp Cooling System to minimize chemotherapy-induced hair loss and improve patient well-being and quality of life. The system provides continuous cooling with high efficacy, safety and acceptable comfort. In the pivotal trial for FDA clearance DigniCap prevented hair loss in 66.3% of patients as published in JAMA February 2017.

DocCheck Medical Services GmbH

doccheck logo

With more than 1,200,000 registrations, DocCheck is Europe’s largest community for healthcare professionals. It allows members of the medical field to share their expertise and network with fellow colleagues. The platform’s various services provide medical knowledge for online learning and encourage professional exchange among peers. The free DocCheck password grants users quick access to websites of pharmaceutical companies and medical publishers which are intended for professionals only.

Dr. Reddy’s Laboratories Ltd.

dr reddys logo

Dr. Reddy’s Laboratories Ltd. is an NYSE-listed, vertically-integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines, because Good Health Can’t Wait. The company manufactures and markets Active Pharmaceutical Ingredients, Finished Dosages and Biologics in over 100 countries worldwide. Headquartered in Hyderabad, India its key markets are US, Europe, India, Russia & CIS and China.  

ECS Screening

ECS screening logo

ECS Screening is committed to revolutionizing the cancer journey for patients, caregivers, and healthcare systems around the world. Our innovative blood-based biomarker test, targeting Progastrin, offers the opportunity to transform cancer screening and monitoring. We are dedicated to improving the understanding of each patient’s cancer state, so that precious health resources can be focused where they are needed most.

  • www.ecs-screening.ch
  • Booth 101

Erytech Pharma

SL-Erytech

Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS platform, which uses a novel technology to encapsulate therapeutic drug substances inside red blood cells, ERYTECH has developed a pipeline of product candidates targeting markets with high unmet medical needs.

Eurofins Biomnis

eurofins biomnis logo

European leader in specialized medical pathology, Eurofins Biomnis carries out over 32,000 analyses per day from a range of over 2,500 available tests. Founded in 1897 by Marcel Mérieux, Eurofins Biomnis is based on a concept of specialised pathology that is entirely dedicated to continuous excellence, innovation and technological investment, particularly in areas such as oncology and personalized medicine.

Europital

europital logo

International organization dedicated to Medical Management of Clinical Research Projects. Providing medical expertise tailored for the medical service needs of our clients in Pharmaceutical and Medical Device industries during their Clinical Research and Drug Development phases. Our team of senior medical experts and experienced research Physicians provides in-depth knowledge and hands–on commitment in various therapeutic areas and disease indications.

EUSA Pharma (UK) Ltd

eusapharma logo

We are a global speciality pharmaceutical company, continuously striving to confront current gaps in patient care. Our ambition drives us to deliver medical treatments that deliver real change to improve patients lives wherever they are needed in the world. 

Exelixis

exelixis logo

Founded in 1994, Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Exelixis is on a mission to help patients recover stronger and live longer.

F.Hoffmann-La Roche AG

Roche logo

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Fresenius Kabi

SL-Fresenius-Kabi

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Product portfolio: I.V. generic drugs, infusion therapies, clinical nutrition and related medical devices, products for whole blood and components collection and processing, transfusion medicine and cell therapy. Fresenius Kabi also develops biosimilars with a focus on oncology and autoimmune diseases.

Gedeon Richter Plc.

gedeon-richter

Gedeon Richter Plc., Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe, China and Latin America. Richter's consolidated sales were approximately EUR 1.4 billion in 2017, reaching a market capitalisation of EUR 4.1 billion. Richter’s product portfolio covers many important therapeutic areas, including Women's Healthcare and Central Nervous System. Richter is also active in biologic product development and committed to bringing biosimilar products to global markets.

geneXplain GmbH

geneXplain logo

Being one of the world’s leading biomedical software suppliers, geneXplain GmbH provides you with key tools for the needs of bioinformatics, cheminformatics, systems biology and systems medicine. We help you to analyze RNA-seq, GWAS, ChIP-seq, methylation, NGS, proteomics and other data for identification of drug targets and biomarkers. Please visit our booth for more product info and technology demonstration.

Genmab

SL-Genmab

Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for cancer treatment. Genmab has two approved antibodies, DARZALEX® (daratumumab) and Arzerra® (ofatumumab). Genmab is recruiting patients for clinical studies with the antibody-drug conjugates tisotumab vedotin and HuMax®-AXL-ADC. Genmab has a broad pipeline and invented the DuoBody® and HexaBody® antibody technology platforms.

Genomic Health

Genomic Health Logo

Genomic Health is the world’s leading provider of genomic-based diagnostic tests that help optimize cancer care. With its Oncotype IQ® Genomic Intelligence Platform, the company is applying its scientific and commercial expertise and infrastructure to translate significant amounts of genomic data into clinically-actionable results for treatment planning throughout the cancer patient's journey. 

Gilead Sciences, Inc.

gilead sciences logo

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

GSK

gsk-logo-2014

GSK Oncology is committed to shaping cancer care through a diverse pipeline of innovative agents and novel combinations. We have established a focused effort in Cancer Epigenetics, Immuno-Oncology, and Oncology Cell Therapy. GSK welcomes collaborations with the oncology R&D community on our investigational agents in solid tumors and hematologic malignancies.

HalioDx

halio dx logo

HalioDx is an immuno-oncology diagnostic company providing oncologists with first-in-class diagnostic products and services to guide cancer care and contribute to precision medicine. Immunoscore®, reflecting the immune response to tumor, is a key hallmark of disease progression and a powerful prognostic assay, already available in colon cancer. HalioDx proposes also assays for clinical research, notably to stratify patients for immunotherapies. 

Halozyme, Inc.

halozyme logo

Halozyme is a clinical-stage biotech focused on developing novel cancer therapies targeting the tumor microenvironment. Lead investigational program PEGPH20 (pegvorhyaluronidase alfa) uniquely targets solid tumors, potentially increasing immune response and tumor access for other therapies. Additionally, Halozyme has partnerships with leading pharmaceutical companies for ENHANZE® drug delivery technology, which may enable and optimize subcutaneous drug delivery for appropriate co-administered therapies.

Healthcare X.0

healthcare X.0 logo

Healthcare X.0 provides an integrated software solution for oncologist. The combination of clinical documentation & reporting through OncoAssist and patient report outcomes, through PatientAssist, provides insights and analytics to improve clinical outcomes and quality of care. Researchers and sponsors can request patient cohorts drawn from a pool of 100,000+ anonymised patient profiles to determine real-world treatment effectiveness. 

Helsinn Healthcare

SL-Helsinn

Helsinn, a private Swiss pharmaceutical group with an extensive portfolio of marketed cancer supportive care products and cancer therapeutics and a robust drug development pipeline, works across pharmaceuticals, biotechnology, medical devices, nutritional supplements to improve the everyday lives of patients. Helsinn has direct local sales in U.S., GMP manufacturing facilities in Switzerland and Ireland, and subsidiaries in Monaco and China.

HTG Molecular Diagnostics

HTG logo

HTG is focused on next generation sequencing (NGS) based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Our mission is to empower precision medicine at the local level.

IBM Watson Health

IBM watson health logo

IBM Watson Health is working to support those fighting against cancer by helping to improve the ability of doctors, researchers and insurers to transform care through knowledge. Cognitive computing can help physicians transform healthcare by helping to redefine how clinical trials are conducted, treatments are considered and care is personalized.  

Ice Cold Mouthpiece

Icecold mouthpiece logo

The Ice Cold Mouthpiece is an easily administered device designed to cool the entire oral cavity during chemotherapy. Contrasted with ice chips, the common alternative for cryotherapy, the Ice Cold Mouthpiece is more effective and efficient. Moreover, it can be used on patients with sensitive teeth or those requiring oxygen masks, potentially broadening treatable patient numbers.

ImaginAb, Inc.

imaginab-logo

ImaginAb, Inc., a bioimaging company, focuses on providing actionable insight into patient selection and treatment progress for cancer immunotherapy, enabling precision medicine. Its proprietary pipeline of imaging products uses the specificity of monoclonal antibodies to create precise images of disease activity. The portfolio of imaging products includes CD8 (IAB22M2C) and CD4 for immune-oncology; and PSMA PET (IAB2M) for prostate cancer.

Immunomedics

immunomedics logo

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer and other serious diseases. Immunomedics’ corporate objective is to become a fully-integrated biopharmaceutical company and a leader in the field of antibody-drug conjugates.

Incyte Biosciences International Sarl

Incyte Logo

Incyte is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.

Institut Curie

institut curie logo

A leading player in the fight against cancer, Institut Curie, founded in 1909 by Nobel Laureate Marie Curie, brings together an internationally-renowned research centre and an advanced hospital group that provides care for all types of cancers, including the rarest forms. Institut Curie was granted the "Comprehensive Cancer Center" label by the Organisation of European Cancer Institutes in 2018.

Invivoscribe, Inc.

Invivoscribe logo

Invivoscribe® offers a full range of hemato-oncology cGMP-manufactured molecular testing products and services, including B- and T-cell clonality assays (IGH, IGK, TRG, TRB), the FDA- and EMA-approved LeukoStrat® CDx FLT3 Mutation Assay, next-generation sequencing (NGS) gene panels and minimal residual disease (MRD) assays with bioinformatics software. We operate a global network of clinical reference laboratories, offering internationally harmonized tests.

Iovance Biotherapeutics

iovance biotherapeutics logo

Driven by scientific vision and grounded in collaboration, Iovance Biotherapeutics is establishing leadership in immuno-oncology by developing Tumor-Infiltrating Lymphocyte (TIL) technology to deliver personalized therapies to patients with unmet medical needs. Actively recruiting phase 2 trials in metastatic melanoma, cervical cancer, squamous cell carcinoma of the head and neck and NSCLC.

IPSEN

Ipsen-logo

Ipsen (Euronext: IPN; ADR: IPSEY) is a global biopharmaceutical group focused on innovation and specialty care. Oncology is one of Ipsen’s focused therapeutic areas with a solid portfolio of innovative medicines. Ipsen focuses its efforts in fighting cancers such as prostate cancer, bladder cancer, neuroendocrine tumors, kidney cancer, breast cancer and other niche oncology diseases.

IQVIA

SL-IQVIA

IQVIA is a leading global provider of information, innovative technology solutions, and contract research services focused on helping healthcare clients find better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA applies human data science to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.

ITM Isotopen Technologien München AG

ITM istopen logo

ITM Isotopen Technologien München AG is a privately held group of companies dedicated to the development, production and global supply of innovative radionuclides and radiopharmaceuticals for targeted cancer diagnostics and therapies. ITM is developing a proprietary portfolio and growing pipeline. Main objectives are to significantly improve outcomes and quality of life for cancer patients while improving health economics through Targeted Radionuclide Therapies in Precision Oncology.

Janssen Pharmaceutical Companies of Johnson & Johnson

Janssen Oncology Logo

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it.

Kidney Cancer Association

kidney cancer association logo

The Kidney Cancer Association is the world’s first international charity dedicated to the eradication of renal cancers. It is the largest kidney cancer charity, with members in more than 100 countries. We educate families and physicians, and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally.

Lilly

Lilly Oncology Logo

For more than fifty years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.

Loxo Oncology, Inc.

Loxo Logo

At Loxo Oncology, our research focuses on developing highly selective medicines for patients with genomically defined cancers. Our programs are designed to leverage recent advances in genomic testing to identify the patients most likely to benefit from medicines that selectively inhibit a single cancer-driving molecular target.

M3 Global Research

M3 global research with wave logo

M3 Global Research offers paid market research opportunities; both online and in-person, with an emphasis on healthcare. M3 respondents receive invitations to participate in studies relevant to their professional interests, help improve patient outcomes and improve new product development. M3’s membership includes over 2 million respondents, incorporating an ISO-certified physician panel.

MacroGenics, Inc

macrogenics logo

MacroGenics is a biopharmaceutical company focused on discovering and developing innovative antibody-based therapeutics for the treatment of cancer. Our pipeline of immuno-oncology product candidates have been created through our proprietary protein engineering platforms, including our DART® bispecific and Fc Optimization technologies. Our product candidates and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe.

medac

SL-medac

medac is a privately held, global pharmaceutical company with a growing pharmaceutical and diagnostics business. Medicinal products from medac support doctors and patients throughout the world in overcoming acute and chronic diseases in the indication areas of oncology, haematology, urology and autoimmune disorders. In addition, medac develops and markets special diagnostic test systems. Since 1970 medac has been committed to unifying therapeutic and diagnostic areas under one roof

Median Technologies

median 2017 logo

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for patient care, iSee® and ImageBank® for clinical trials, and iBiopsy® for imaging diagnostics, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor and assess response to therapy.

Medifood

medifood logo

Medifood is a medical nutrition company offering innovative and unique clinical nutritional products based on the latest body of scientific evidence for patients affected by disease-related malnutrition.

Medscape Oncology

medscape oncology logo

Medscape Oncology is the leading source of oncology & hematology news and information for physicians and other healthcare professionals worldwide. We offer medical news, including practice guidelines, FDA announcements, journal articles conference news, and thought leader perspectives; point-of-care clinical reference tools; and continuing medical education in a variety of engaging formats.

Merck

Merck KGaA

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

MGZ - Medical Genetics Center

MGZ medical genetics center logo

The MGZ – Medical Genetics Center has been providing diagnostic genetic testing and counseling services for over 15 years in the center of Munich. Analyses are performed in our accredited medical genetics lab and interpreted by both our 12 clinical geneticists and scientific team, supporting clinicians worldwide in the diagnosis and care of their patients.

Molecular Health GmbH

molecular health logo

Molecular Health, based in Heidelberg, Germany, develops and provides IT-driven products and services for use in precision medicine. Our focus area is treatment decision support in oncology (medical device application) and we actively extend our research and development activities into many other areas of precision healthcare for better, faster insights into drug discovery, safety and commercialization. 

MSD

MSD Inventing for Life logo

For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.

Mylan

mylan logo

Given the very real global need, Mylan is committed to bringing biosimilars to market and already has a 20-strong portfolio under development across multiple therapy areas. Mylan’s belief is that7 billion people across the globe deserve access to high-quality, affordable medicine. Mylan is committed to helping patients get the treatment they need.

Myriad Genetics

myriad genetics logo

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient’s lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

NanoString Technologies

Nanostring Logo

NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 2,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System.

NeoGenomics

SL-NeoGenomics

NeoGenomics specializes in cancer genetics testing and information services with the most comprehensive oncology-focused testing menus globally to diagnose and treat cancer. NeoGenomics operates CLIA certified laboratories serving the needs of pathologists, oncologists, academic centers, hospital systems, Pharma, and managed care organizations. 

Noona Healthcare

noona logo

Noona is a cloud-based mobile platform designed to capture and improve patient-reported symptoms and treatment outcomes in the real world clinical practice. We transform the patient experience, delivering better cancer care, improving survival and saving clinical resources. Noona is a solution with unmatched high patient and clinical user adherence, activity and engagement across all age groups, which gives us the unrivalled competitive advantage of gathering consistent, high quality data. 

Novartis Oncology

Novartis

At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. 

Novella Clinical

novella clinical logo

Novella Clinical, a Quintiles company, is a full-service clinical research organization (CRO) with headquarters in Morrisville, NC and operations in the Americas, Europe and Asia. Novella is focused on the unique needs of oncology, dermatology and medical device companies. Novella integrates deep clinical and therapeutic expertise, operational excellence, and a superior level of customer service to streamline product development.

Novosanis NV

novosanis logo

Novosanis is a Belgian award-winning innovative developer and producer of medical devices, active in the fields of infectious diseases and oncology. Novosanis has two device platforms in portfolio : VAX-ID for accurate intradermal drug delivery and Colli-Pee(CE-IVD & FDA listed)for standardized first-void urine sampling adding value to the accuracy of diagnostic tests.

Nutricia Advanced Medical Nutrition

nutricia amn logo

Nutricia Advanced Medical Nutrition, a specialised business of Danone, focusses pioneering nutritional solutions that help people live healthier and longer lives. Nutricia aims to establish medical nutrition as an integral part of healthcare. Nutricia's extensive range of evidence-based nutrition products and services offer proven benefits and better patient outcomes and works with doctors and HCPs in 40 countries to deliver better care and to lower the cost of care.

Omnicare Holding GmbH & Co. KG

omnicare logo

Omnicare, a joint venture of cytostatic producing pharmacies is dedicated to maintain and guarantee the future of ambulatory care in oncology in Germany. We develop and implement processes to ensure quality and safety for preparation of cytostatic drugs. Furthermore, we provide hands-on trainings for HCP, as well as building a nationwide quality network of oncologists to improve patient care continually.

ONCARE GmbH

oncare logo

ONCARE is an innovative young company seeking to make a change in patients’ health through the digitalization of healthcare management and consolidation of patient clinical data. At ONCARE we are committed to giving the best possible technological support that can help you enhance treatment quality and avoid mistakes caused by stress and hectic pace in the daily routine.

OncLive®

onclive logo

OncLive® is the official Website for the Oncology Specialty Group, which publishes OncologyLive, Urologists in Cancer Care, Oncology Business Management, and Oncology Nursing News. The mission of OncLive® and these publications is to provide oncology professionals with the resources and information they need to provide the best patient care. OncLive® is also home to the Peer Exchange and Insights video editorial series, which provide a unique opportunity to view lively discussions with authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

OncoDNA

oncoDNA Logo

OncoDNA, the healthcare technology company making precision medicine a reality, aims to lead oncologists worldwide through the best treatment options for each patient individually. We combine advanced, comprehensive testing of disease biomarkers with a cancer treatment knowledge database which continuously ‘learns’ from scientific and medical advances

Oncology Knowledge into Practice

onkip-logo

Oncology Knowledge into Practice is a new educational platform offering free, interactive ways for HCPs to stay informed of new developments and their relevance to local practice. These CME-accredited programmes translate global-level information into local-level recommendations, ensuring HCPs can implement cutting-edge knowledge into their clinical practice.

Oncology Learning Network

SL-Oncology-Learning-Network

Oncology Learning Network® is an online resource for the latest developments in oncology practice, providing a customized experience for readers to stay informed about the topics that matter most. Through clinical insights, peer-reviewed articles, news updates, accredited CE programs and live meetings, the Network serves as a collaborative learning & networking environment for a multidisciplinary community of oncology medical professionals.

Oncompass Medicine

oncompass logo

Oncompass Medicine, a molecular health information company, developed a rule-based AI system for precision oncology – the RealTime Oncology Treatment Calculator; using a standardised, reproducible and objective treatment ranking method to rank more than 960 drugs in 370 tumour types based on 20.000 rules, to interpret or re-interpret multigene molecular test results from different laboratories.

PAXMAN

Paxman Logo

As the global expert in preventing Chemotherapy-induced Alopecia (CIA), Paxman’s pioneering scalp cooling system has helped thousands of people worldwide to keep their hair and dignity during cancer treatment. Paxman know first-hand that CIA is often devastating. Patient care is at our heart: our goal is to ensure everyone, has the opportunity to maintain normality, retain their hair and self-confidence.

Paxxo

paxxo logo

Paxxo is Swedish based packaging company with a 40-year history. Our business concept is to manufacture the unique endless bag system Longopac that, thanks to innovative, smarter waste management and packaging solutions, creates a better working environment for all industries. Our main product for hazardous waste handling is Pactosafe, a waste sealing unit for safe airtight sealing of cytotoxic waste.

PER Global, LLC

PER global logo

PER Global, LLC is a medical education company with a focus on oncology and hematology. Since 2015, we have executed multiple EACCME-accredited congresses and webcasts throughout Europe, featuring internationally-renowned faculty, that enable healthcare professionals to remain current and responsive to advances in medical care for patients with cancer. 

Pfizer Oncology

Pfizer-oncology-logo-2016

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference on the lives of patients. Today, Pfizer Oncology has an industry-leading portfolio of more than 10 approved cancer medicines across numerous indications, including breast, prostate, kidney, lung and hematology. Pfizer Oncology is striving to change the trajectory of cancer.

Pharmadab d.o.o.

Pharmadab Green and Brown Logo

Pharmadab was established in 2002 as a Pharmaceutical Engineering Company. Pharmadab is an innovative pharmaceutical company that produces medical devices in the field of oncological supportive care, developed on its own research. Our pharmaceutical products are sold in pharmacies and other specialized shops throughout Europe and the world.

PharmaMar

SL-PharmaMar

PharmaMar is a global biopharmaceutical company, focused on oncology and committed to research and development. PharmaMar’s Yondelis® was the first antitumor drug of marine origin to be approved for commercialization, specifically to treat soft tissue sarcoma. It has obtained approval for treating ovarian cancer in the European Union. It is available in the main oncology markets: the US, Europe and Japan.

Philips Molecular

philips logo

Philips OncoSignal Molecular Pathway Diagnostics reveals the activity of the signal transduction pathways that drive tumor growth, having the potential to offer accurate therapy response prediction for informed personalized cancer treatment decisions. This is achieved by measuring mRNA transcribed from target genes of the pathway transcription factors, and data interpretation with computational pathway models.

Pierre Fabre

Pierre Fabre Oncology Logo

Pierre Fabre is a French multinational, privately-owned pharmaceutical and cosmetic company present in 130 countries. Oncology is one of our priorities, with programs focusing particularly on targeted therapies, biotherapies and immuno-oncology. We work in therapeutic areas of high unmet medical need, including onco-hematology and onco-dermatology. Thanks to our experience in both innovation and manufacturing, we are now recognized as one of the leading global names in oncology. 

Pivotal

Pivotal Logo

Founded in 2001, Pivotal is a leading full-services European CRO offering services to the healthcare industry. We take on the immense challenges for supporting cutting-edge clinical development programmes, especially in the Oncology and Haemato-Oncology areas. Our clients enjoy the benefits of senior management hands-on environment, operational teams working directly with the clinical sites, deep therapeutic expertise and cost-effective deliverables.

Precision for Medicine, Oncology and Rare Disease

precision for medicine logo

Precision for Medicine, Oncology and Rare Disease is proud to offer the first comprehensive, fully integrated clinical development solution. We are devoted exclusively to oncology and rare disease, and our teams are passionate about improving the lives of these patients. By combining the progressive science of biomarkers and analytics with our excellence in complex clinical trial execution, we help innovators to invest wisely, discover value sooner and optimize the returns from research. 

priME Oncology

prIME Logo

prIME Oncology is the world’s leading provider of independent medical education in oncology and hematology. At prIME Oncology, we provide evidence-based educational activities that define today’s best practices and prepare healthcare professionals to integrate cutting-edge innovations into patient care. 

Puma Biotechnology

puma biotechnology logo

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families and the breast cancer community.

Rakuten Aspyrian, Inc.

rakuten aspyrian logo

Rakuten Aspyrian is a privately funded, clinical-stage Biotechnology Company based in California, USA. Our novel proprietary photoimmunotherapy technology uses antibodies conjugated with payloads that are specifically activated at the tumor site. Our first clinical product has advanced into Phase 3 pivotal clinical testing to treat recurrent HNSCC.

Richter Gedeon Plc.

richter-gedeon

Gedeon Richter Plc., Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe, China and Latin America. Richter's consolidated sales were approximately EUR 1.4 billion in 2017, reaching a market capitalisation of EUR 4.1 billion. Richter’s product portfolio covers many important therapeutic areas, including Women's Healthcare and Central Nervous System. Richter is also active in biologic product development and committed to bringing biosimilar products to global markets.

Sandoz

Sandoz Novartis

Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. We pioneer novel approaches to drive access to medicine. Our portfolio comprises approximately 1000 molecules and our products reach well over 500 million patients

Sanofi Genzyme

Sanofi Genzyme Logo

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.

Seattle Genetics

seattle genetics logo

Seattle Genetics, an emerging multi-product, global biotechnology company, develops and commercialises transformative cancer-targeting therapies. Our lead product ADCETRIS® (brentuximab vedotin) is marketed in over 70 countries worldwide. Seattle Genetics has a robust product pipeline designed to address significant unmet needs. Seattle Genetics is headquartered in the US, with European and International operations located in Switzerland. 

SeraCare Life Sciences, Inc.

seracare logo

SeraCare is a leading partner to global IVD manufacturers and clinical testing laboratories. Our expanding portfolio of QC products and technologies for genomic diagnostics includes reference materials for tumor sequencing, germline mutation testing, NIPT, and infectious disease. Today, SeraCare is advancing data integration with products for better QC and regulatory compliance.

Servier

Servier

Servier is an international pharmaceutical company governed by a non-profit Foundation and employs over 21,600 people worldwide.
Entirely independent, the Group reinvests 25% of its turnover into research and development. Corporate growth is driven by Servier’s constant search for innovation. Becoming a key player in oncology is part of Servier’s long-term strategy, which is why the Group devotes 37% of its R&D investments to fighting cancer and addressing critical unmet patients’ needs, with the goal of reaching 50% within the next two years.

SIVAN INNOVATION LTD

sivan innovation logo

SIVAN INNOVATION is an innovative Med-tech company serving healthcare professionals and patients. SIVAN is essentially dedicated to designing, evaluation, validating and developing innovative IT health applications. Sivan developed MoovCare, the first web application for the early detection of relapses and complications of lung cancer patients.

SOPHiA GENETICS

SL-SOPHiA-GENETICS

Global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. Enabling rapid adoption of genomic testing worldwide, turning data into actionable insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to save lives equally.

Sotio a.s.

SL-Sotio

SOTIO is building a diverse biotechnology portfolio through own R&D, partnering and investments. It’s focusing on developing of new methods of the treatment of cancer. The most advanced project is a proprietary platform of active cellular immunotherapy based on dendritic cells. SOTIO is conducting multiple Phase I to III clinical trials and projects in preclinical stage. SOTIO has facilities in Europe, the US, China and Russia.  

Springer Healthcare/ Medicine Matters

medicine matters oncology logo

Medicine Matters oncology is a free to access premier resource for healthcare professionals working with cancer patients.

Guided by our Advisory Board, Medicine Matters will:

  • Be a trusted online source of daily news, medical information, and expert opinion
  • Provide summarize clinical content in bite-sized formats
  • Deliver educational tools to support professional development

Stemline Therapeutics

  • Booth 281

Stilla Technologies

stilla technologies

Stilla Technologies focuses on accelerating the development of next-generation genetic tests by providing innovative instrumentation for digital PCR. In 2016, Stilla Technologies launched the Naica System, the first and only dPCR solution to offer 3-color multiplexing. Other key features of the system are the speed, simplicity and versatility of its workflow.

Syneos Health

syneos health logo

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization and Contract Commercial Organization , is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 23,000 clinical and commercial minds with the ability to support customers in more than 110 countries.

Sysmex Inostics / Sysmex Europe

SL-Sysmex

Sysmex is a global leader in diagnostics solutions with advanced technologies improving cancer management. Sysmex Inostics, a subsidiary of Sysmex Corporation, is a pioneer in liquid biopsy diagnostics with technologies such as OncoBEAM digital PCR and Plasma Safe Seq NGS providing new assays for clinical applications in oncology and offering global services for pharmaceutical companies – from discovery to companion diagnostics. 

Takeda Oncology

takeda oncology

We endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. Our combined legacy in oncology includes a broad range of paradigm-changing therapies for hematologic cancers and solid tumors. Our mission is not simple but we are up to the task: We aspire to cure cancer.

TESARO

Tesaro Logo

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people facing cancer. We see new possibilities to responsibly develop and commercialize innovative treatments where others may not. Relationships are vital to the success of our business, and we are committed to being a trusted partner to the cancer community.

TEVARIS GmbH

tevaris logo

TEVARIS® - Innovative software solutions for oncology and specialized medical practices. TEVARIS® is helping hospitals and private practices with intelligent software solutions for digital tumor documentation and therapy accompaniment. Increased efficiency through intelligent data acquisition and evaluation ensures more medically effective and valuable therapies and thus facilitates the everyday clinical routine. 

The Cancer Drug Development Forum

CDDF logo 2015

The Cancer Drug Development Forum (CDDF) is a not-for-profit organization. CDDF is a unique platform facilitating interactions between all stakeholders to improve the efficiency of cancer drug development. Representatives from academia, pharmaceutical industries, regulatory and policy authorities as well as patient advocates can together meet and exchange expertise to find the ways to expedite effective oncology drug development and delivery.

Thermo Fisher Scientific

SL-Thermo-Fisher-Scientific

Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We support precision oncology progress and implementation with innovative technologies and service through our brands. We offer next generation sequencing tests for genomic profiling of solid and hematological tumors including liquid biopsy and immuno oncology applications. 

TRIO-Translational Research in Oncology

TRIO translational research in oncology logo

TRIO is a not-for-profit academic CRO specialized in oncology. Their unique model offers full services coupled with strong scientific leadership bridging translational science with operations. Add the power of their international investigator network and TRIO can assist sponsors in expediting their drug development. TRIO takes pride in its history of executing trials with the highest opportunity to change patients’ lives.

Ultivue, Inc.

ultivue-logo

Ultivue develops high-performance reagents for biological imaging in situ by combining multiplexing at high speed and spatial resolution. Ultivue enables translational and clinical researchers to decipher complex mechanisms of cancer and identify of biomarker signatures to better match patients to therapeutic options. Ultivue products and services integrate into existing workflows for biomarker discovery, assay validation, and companion diagnostic applications.

Varian

varian logo

Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world.

WeHealth by Servier

wehealth logo

Servier will also offers eHealth such as ON’COHUB, a cloud-based imaging platform built on the RECIST criteria, that could be directly used by oncologists and radiologists to better follow tumor evolution during cancer treatments in clinical trials. It could be used in routine to optimize patient follow-up.

  • Booth 211

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.